236 related articles for article (PubMed ID: 26022775)
1. Properties and Clinical Relevance of Speckle-Type POZ Protein in Human Colorectal Cancer.
Xu J; Wang F; Jiang H; Jiang Y; Chen J; Qin J
J Gastrointest Surg; 2015 Aug; 19(8):1484-96. PubMed ID: 26022775
[TBL] [Abstract][Full Text] [Related]
2. Speckle-Type POZ Protein Down-Regulates Matrix Metalloproteinase 2 Expression via Sp1/PI3K/Akt Signaling Pathway in Colorectal Cancer.
Zhang S; Xiao J; Chai Y; Hong Z; Liu Z; Yuan R; Luo Z; Zhou X; Lucero-Prisno DE; Huang K
Dig Dis Sci; 2018 Feb; 63(2):395-402. PubMed ID: 29260353
[TBL] [Abstract][Full Text] [Related]
3. Silencing speckle-type POZ protein by promoter hypermethylation decreases cell apoptosis through upregulating Hedgehog signaling pathway in colorectal cancer.
Zhi X; Tao J; Zhang L; Tao R; Ma L; Qin J
Cell Death Dis; 2016 Dec; 7(12):e2569. PubMed ID: 28032859
[TBL] [Abstract][Full Text] [Related]
4. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
[TBL] [Abstract][Full Text] [Related]
5. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
[TBL] [Abstract][Full Text] [Related]
6. miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2.
Zheng YB; Luo HP; Shi Q; Hao ZN; Ding Y; Wang QS; Li SB; Xiao GC; Tong SL
World J Gastroenterol; 2014 Jun; 20(21):6515-22. PubMed ID: 24914372
[TBL] [Abstract][Full Text] [Related]
7. Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation.
Yang K; Jiang L; Hu Y; Yu J; Chen H; Yao Y; Zhu X
J Exp Clin Cancer Res; 2015 May; 34(1):40. PubMed ID: 25935853
[TBL] [Abstract][Full Text] [Related]
8. STIP1 knockdown suppresses colorectal cancer cell proliferation, migration and invasion by inhibiting STAT3 pathway.
Xia Y; Chen J; Liu G; Huang W; Wei X; Wei Z; He Y
Chem Biol Interact; 2021 May; 341():109446. PubMed ID: 33766539
[TBL] [Abstract][Full Text] [Related]
9. MICAL1 inhibits colorectal cancer cell migration and proliferation by regulating the EGR1/β-catenin signaling pathway.
Gu H; Li Y; Cui X; Cao H; Hou Z; Ti Y; Liu D; Gao J; Wang Y; Wen P
Biochem Pharmacol; 2022 Jan; 195():114870. PubMed ID: 34902339
[TBL] [Abstract][Full Text] [Related]
10. Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells.
Ma K; Pan X; Fan P; He Y; Gu J; Wang W; Zhang T; Li Z; Luo X
Mol Cancer; 2014 May; 13():118. PubMed ID: 24885288
[TBL] [Abstract][Full Text] [Related]
11. The MiR-495/Annexin A3/P53 Axis Inhibits the Invasion and EMT of Colorectal Cancer Cells.
Bai Z; Wang J; Wang T; Li Y; Zhao X; Wu G; Yang Y; Deng W; Zhang Z
Cell Physiol Biochem; 2017; 44(5):1882-1895. PubMed ID: 29224019
[TBL] [Abstract][Full Text] [Related]
12. SPOP suppresses tumorigenesis by regulating Hedgehog/Gli2 signaling pathway in gastric cancer.
Zeng C; Wang Y; Lu Q; Chen J; Zhang J; Liu T; Lv N; Luo S
J Exp Clin Cancer Res; 2014 Sep; 33(1):75. PubMed ID: 25204354
[TBL] [Abstract][Full Text] [Related]
13. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
15. MiR-199a-5p loss up-regulated DDR1 aggravated colorectal cancer by activating epithelial-to-mesenchymal transition related signaling.
Hu Y; Liu J; Jiang B; Chen J; Fu Z; Bai F; Jiang J; Tang Z
Dig Dis Sci; 2014 Sep; 59(9):2163-72. PubMed ID: 24711074
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW
Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553
[TBL] [Abstract][Full Text] [Related]
17. CSRP2 suppresses colorectal cancer progression
Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
[TBL] [Abstract][Full Text] [Related]
18. High TrkB expression levels are associated with poor prognosis and EMT induction in colorectal cancer cells.
Fujikawa H; Tanaka K; Toiyama Y; Saigusa S; Inoue Y; Uchida K; Kusunoki M
J Gastroenterol; 2012 Jul; 47(7):775-84. PubMed ID: 22361863
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
Li C; Cai S; Wang X; Jiang Z
Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin.
Xiao S; Liu L; Lu X; Long J; Zhou X; Fang M
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1465-74. PubMed ID: 25716692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]